<?xml version="1.0" encoding="UTF-8"?>
<ref id="B117">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Qi</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kawana-Tachikawa</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2010</year>). 
  <article-title>Novel immunodominant peptide presentation strategy: a featured HLA-A
   <sup>*</sup>2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein
  </article-title>. 
  <source>J. Virol.</source>
  <volume>84</volume>, 
  <fpage>11849</fpage>â€“
  <lpage>11857</lpage>. 
  <pub-id pub-id-type="doi">10.1128/jvi.01464-10</pub-id>
  <pub-id pub-id-type="pmid">20844028</pub-id>
 </mixed-citation>
</ref>
